Abstract
Bipolar disorders I and II (BPD) is a common, severe and recurrent mood disorder associated with high rates of comorbidities, suicide, dysfunction and a high socio-economic burden. Although the management of BPD has traditionally focused on the acute treatment of mania, the chronic nature of BPD necessitates long-term maintenance treatment. Bipolar depression is the predominant mood state in BPD and causes greater disability and economic burden than mania. Maintenance pharmacotherapy can reduce rates of future episodes, and subsequently, the associated risks, functional disability and economic burden of bipolar illness. Copyrigth
| Translated title of the contribution | Pharmacotherapy for bipolar depression: An economic assessment |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 264-269 |
| Number of pages | 6 |
| Journal | Salud(i)Ciencia |
| Volume | 16 |
| Issue number | 3 |
| State | Published - Aug 1 2008 |
Keywords
- Bipolar depression
- Bipolar disorder
- Maintenance treatment
- Pharmacoeconomics
- Pharmacotherapy
ASJC Scopus subject areas
- Medicine(all)